Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis

被引：7
|
作者：
Gao, Xue-min [1 ,2 ]
Li, Jian [1 ,2 ]
Cao, Xin-xin [1 ,2 ]
机构：
[1] Peking Union Med Coll Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China
来源：
CELL COMMUNICATION AND SIGNALING | 2022年 / 20卷 / 01期
基金：
北京市自然科学基金;
关键词：
Langerhans cell histiocytosis (LCH); MAPK pathway; Inflammatory myeloid malignancy; Progenitor cells; RAF inhibitors; MEK inhibitors; ERDHEIM-CHESTER DISEASE; DENDRITIC CELL; T-CELLS; ABUNDANT EXPRESSION; HIGH PREVALENCE; BRAF MUTATIONS; VEMURAFENIB; LCH; INHIBITION; MAP2K1;
D O I：
10.1186/s12964-022-00917-0
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the "L-group " histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK pathway activation in the development of histiocytosis are still elusive. This review will summarize research concerning the landscape and pathogenic roles of MAPK pathway mutations and related treatment opportunities in Langerhans cell histiocytosis.
引用
收藏
页数：16
相关论文
共 50 条
  • [1] Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis
    Xue-min Gao
    Jian Li
    Xin-xin Cao
    Cell Communication and Signaling, 20
  • [2] The cutaneous Langerhans cell histiocytosis microenvironment
    Harikumar, P. E.
    Selway, J.
    Chu, A.
    Langlands, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : e29 - e30
  • [3] NOTCH SIGNALING IN LANGERHANS CELL HISTIOCYTOSIS
    Hutter, Caroline
    Kauer, Max
    Simonitsch, Ingrid
    Jug, Gunhild
    Minkov, Milen
    Gadner, Helmut
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E77 - E77
  • [4] Langerhans cell histiocytosis: Current concepts and treatments
    Abla, Oussama
    Egeler, R. Maarten
    Weitzman, Sheila
    CANCER TREATMENT REVIEWS, 2010, 36 (04) : 354 - 359
  • [5] Exploring the composition of and interaction of the tumor microenvironment in Langerhans cell histiocytosis
    van Midden, Wouter
    Schwentner, Raphaela
    Eder, Sebastian
    Ben Soussia-Weiss, Philipp
    Abagnale, Giulio
    Hutter, Caroline
    CANCER RESEARCH, 2024, 84 (22)
  • [6] Immune microenvironment associated with the severity of Langerhans cell histiocytosis in children
    Cai, Fengqing
    Peng, Zhaoyang
    Xu, Hui
    Gao, Hui
    Liao, Chan
    Xu, Xiaojun
    Guo, Xiaoping
    Gu, Weizhong
    Zhu, Kun
    Shu, Qiang
    Shen, Hongqiang
    CYTOKINE, 2023, 171
  • [7] Immune Microenvironment in Langerhans Cell Histiocytosis: Potential Prognostic Indicators
    Feng, Chuchu
    Li, Yang
    Ke, Huang
    Peng, Xiaomin
    Guo, Haixia
    Zhan, Liping
    Xiong, Xilin
    Weng, Wenjun
    Li, Jiaqiang
    Fang, Jianpei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies
    Hutter, Caroline
    Minkov, Milen
    IMMUNOTARGETS AND THERAPY, 2016, 5 : 81 - 91
  • [9] Langerhans cell and non Langerhans cell histiocytosis
    Stéphan, JL
    ARCHIVES DE PEDIATRIE, 2002, 9 (09): : 934 - 941
  • [10] Langerhans' cell histiocytosis
    Devine, JC
    McWilliam, L
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1998, 36 (04): : 318 - 318
12345